Hackett Group

HCKT · NASDAQ

$11.85+$0.56 (+4.96%)TodayMarket closed · Oct 20, 5:17 PM ET

Prev close $11.29

HCKT analyst rating

BuyConsensus of 1 analyst over the last 12 months. 100% rate it a buy.

Strong buy0
Buy1
Hold0
Underperform0
Sell0

12-month price target · 5 analysts

Average $17.00 (+43.5% upside)

Low: $15.15
Now: $11.85
High: $19.95

Upgrades and downgrades

The latest rating actions, newest first

HCKT analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Barrington Research	May 6, 2026	Maintains	Outperform	$17.00 → $16.00	50%
Barrington Research	Apr 23, 2026	Maintains	Outperform	$17.00	50%
Barrington Research	Mar 23, 2026	Maintains	Outperform	$17.00	50%
Barrington Research	Feb 18, 2026	Maintains	Outperform	$27.00 → $17.00	50%
Barrington Research	Feb 5, 2026	Maintains	Outperform	$27.00	50%
Barrington Research	Oct 27, 2025	Maintains	Outperform	$27.00	50%

The case for and against

Updated Oct 14, 2026

Bull case

Hackett Group is viewed favorably because its Gen AI and enterprise transformation platform is positioned to benefit from a mix shift toward AI services and broader adoption of AI-based implementation tools, which management expects to improve gross and adjusted EBITDA margins in the second half of 2026 and beyond. Despite a soft Q1/26, with net revenue of $67.8 million, non-GAAP EPS of $0.34, and adjusted EBITDA of $13.8 million, the company still maintained 20.3% adjusted EBITDA margins, continued share repurchases, and had $22.0 million remaining under its authorization alongside a newly declared $0.12 dividend. The outlook also reflects valuation support, as the shares trade at a 19% discount to peers on 2026 non-GAAP EPS estimates, while the IBM AI partnership and healthy sales pipelines suggest eventual revenue recovery across Oracle, SAP, and Global S&BT.

Bear case

Hackett Group is facing a negative fundamental backdrop because Q1/26 revenue of $67.8 million missed both internal and FactSet expectations by 5%, while non-GAAP EPS of $0.34 also fell short of the $0.35 forecast despite a 70 bps adjusted EBITDA margin beat. The core GSBT business, which generated 54% of Q1/26 revenue, declined 15% year over year and 6% sequentially as elongated AI sales cycles and weak market sentiment slowed demand, while Oracle Solutions fell 24% year over year, underscoring broad execution and demand pressure. With 2026 and 2027 EPS estimates cut to $1.50 and $1.68 from $1.64 and $1.78, and Q1/26 EBITDA margins expected to slip to 19.6% from 20.7%, the outlook reflects both top-line deterioration and weaker earnings power.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.